4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
Evidence-based guide to trazodone pharmacogenomics and dosing considerations specific to Hispanic and Latino populations, including CYP2D6 and CYP3A4 variant frequencies, metabolic comorbidities, and clinical monitoring.
East Asian patients metabolize trazodone differently due to CYP2C19 and CYP2D6 genetic variants. Learn how these differences affect safety, sedation risk, and optimal starting doses.
A clinical review of why trazodone's effects and side-effect profile may differ in South Asian patients, covering CYP2D6 pharmacogenomics, trial representation gaps, cardiometabolic risk context, and questions for a prescriber to discuss.
A clinical review of trazodone pharmacogenomics, dosing considerations, and safety differences in Black and African ancestry patients, with ethnicity-stratified data and guideline citations.